Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug
- 1 January 1992
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 29 (5) , 396-400
- https://doi.org/10.1007/bf00686010
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy.Proceedings of the National Academy of Sciences, 1990
- Low-Density Lipoprotein e (LDL) Distribution Shown by 99mTechnetium-LDL Imaging in Patients with Myeloproliferative DiseasesAnnals of Internal Medicine, 1989
- Amelioration of vincristine neurotoxicity by glutamic acidThe American Journal of Medicine, 1988
- Delivery of Lipophilic Drugs Using LipoproteinsaAnnals of the New York Academy of Sciences, 1987
- Vincristine NeurotoxicityMedical Toxicology, 1986
- An Enzyme-Linked Immunosorbent Assay for the Antineoplastic Agent VincristineJournal of Immunoassay, 1986
- HYPOCHOLESTEROLAEMIA IN MALIGNANCY DUE TO ELEVATED LOW-DENSITY-LIPOPROTEIN-RECEPTOR ACTIVITY IN TUMOUR CELLS: EVIDENCE FROM STUDIES IN PATIENTS WITH LEUKAEMIAThe Lancet, 1985
- Selective uptake of a toxic lipophilic anthracycline derivative by the low density lipoprotein receptor pathway in cultured fibroblastsJournal of Medicinal Chemistry, 1985
- Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjectsBiochemical Journal, 1984
- Low-density lipoprotein metabolism in mice with soft tissue tumoursBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984